Diabetes, a prevalent chronic disorder, is frequently complicated by diabetes-associated cognitive dysfunction (DACD). The impact of diabetes on specific cerebral regions accelerates the progression from mild cognitive impairment to Alzheimer's disease. Research has indicated that mitochondrial dysfunction is a pivotal factor in DACD, yet its underlying mechanisms remain elusive.
Objective
Our research aims to elucidate the research trends in this field over the past fifteen years by employing bibliometric analysis.
Methods
A systematic search and aggregation of literatures related to mitochondrial dysfunction in DACD published within the Web of Science Core Collection from 2010 to 2024 were performed. Subsequently, a bibliometric analysis was conducted employing four bibliometric software: HistCite, R-bibliometrix, VOSviewer, and CiteSpace.
Results
A total of 309 papers were identified for analysis. The most prolific country, institution, and authors were China, University of Coimbra, Moreira PI, and Li YS, respectively. The USA, Texas Tech University, and Reddy PH were the key country, institution, and author, respectively. Among references to articles in this field, Diabetes has the most cumulative citations. According to the analysis of co-citations, oxidative stress was the largest cluster. The primary keywords were “Alzheimer's disease” and “oxidative stress”. In recent years, the keyword “mitophagy” has received a lot of attention.
Conclusions
Oxidative stress represents a principal research topic within this field. Mitophagy offers a potential therapeutic avenue for DACD and may emerge as a novel focus of future investigations.
ValenciaWMFlorezH. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. Br Med J2017; 356: j1018.
2.
BiesselsGJWhitmerRA. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia2020; 63: 3–9.
3.
DingXYinLZhangL, et al.Diabetes accelerates Alzheimer’s disease progression in the first year post mild cognitive impairment diagnosis. Alzheimers Dement2024; 20: 4583–4593.
GundelfingerEDDieckST. Molecular organization of excitatory chemical synapses in the mammalian brain. Naturwissenschaften2000; 87: 513–523.
7.
ChamberlainKAShengZH. Mechanisms for the maintenance and regulation of axonal energy supply. J Neurosci Res2019; 97: 897–913.
8.
DadsenaSKingLEGarcia-SaezAJ. Apoptosis regulation at the mitochondria membrane level. Biochim Biophys Acta-Biomembr2021; 1863: 183716.
9.
RizzutoRDe StefaniDRaffaelloA, et al.Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol2012; 13: 566–578.
10.
ZhangBPanCFengC, et al.Role of mitochondrial reactive oxygen species in homeostasis regulation. Redox Rep2022; 27: 45–52.
11.
OrtizGGHuertaMGonzalez-UsigliHA, et al.Cognitive disorder and dementia in type 2 diabetes mellitus. World J Diabetes2022; 13: 319–337.
12.
ChenCHuZLiuS, et al.Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther2012; 12: 593–608.
13.
ZhaoSJiXYuanG, et al.A bibliometric analysis of the spatial transcriptomics literature from 2006 to 2023. Cell Mol Neurobiol2024; 44: 50.
14.
PanXYanECuiM, et al.Examining the usage, citation, and diffusion patterns of bibliometric mapping software: a comparative study of three tools. J Informetr2018; 12: 481–493.
15.
WangCLiangQHeS, et al.Role of inflammation and immunity in vascular calcification: a bibliometric and visual analysis, 2000-2022. Front Cardiovasc Med2023; 10: 1258230.
16.
van EckNJWaltmanL. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics2010; 84: 523–538.
17.
LiuYChenCZhouY, et al.Twenty years of research on borderline personality disorder: a scientometric analysis of hotspots, bursts, and research trends. Front Psychiatry2024; 15: 1361535.
18.
AriaMCuccurulloC. Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr2017; 11: 959–975.
19.
ChenC. Citespace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci2006; 57: 359–377.
20.
QinYZhangQLiuY. Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain. Brain Res Bull2020; 156: 15–24.
21.
TalbotKWangHYKaziH, et al.Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest2012; 122: 1316–1338.
22.
WangFWangLSuiG, et al.IGF-1 alleviates mitochondrial apoptosis through the GSK3β/NF-κB/NLRP3 signaling pathway in LPS-treated PC-12 cells. J Mol Neurosci2021; 71: 1320–1328.
23.
FrankoAKunzeABoeseM, et al.Impaired insulin signaling is associated with hepatic mitochondrial dysfunction in IR+/−-IRS-1+/− double heterozygous (IR-IRS1dh) Mice. Int J Mol Sci2017; 18: 1156.
24.
SadabaMCMartin-EstalIPucheJE, et al.Insulin-like growth factor 1 (IGF-1) therapy: mitochondrial dysfunction and diseases. Biochim Biophys Acta-Mol Basis Dis2016; 1862: 1267–1278.
25.
ArnoldSEArvanitakisZMacauley-RambachSL, et al.Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol2018; 14: 168–181.
26.
BiesselsGJDespaF. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol2018; 14: 591–604.
27.
BaduiniIRVildosolaJECKavehmoghaddamS, et al.Type 2 diabetes mellitus and neurodegenerative disorders: the mitochondrial connection. Pharmacol Res2024; 209: 107439.
28.
CandeiasESebastiaoICardosoS, et al.Brain GLP-1/IGF-1 signaling and autophagy mediate exendin-4 protection against apoptosis in type 2 diabetic Rats. Mol Neurobiol2018; 55: 4030–4050.
29.
CardosoSCorreiaSCSantosRX, et al.Hyperglycemia, hypoglycemia and dementia: role of mitochondria and uncoupling proteins. Curr Mol Med2013; 13: 586–601.
30.
CarvalhoCCorreiaSCSeicaR, et al.WWOX Inhibition by Zfra1-31 restores mitochondrial homeostasis and viability of neuronal cells exposed to high glucose. Cell Mol Life Sci2022; 79: 487.
31.
CarvalhoCMachadoNMotaPC, et al.Type 2 diabetic and Alzheimer’s disease mice present similar behavioral, cognitive, and vascular anomalies. J Alzheimers Dis2013; 35: 623–635.
32.
CardosoSMoreiraPISoderbomG, et al.Antidiabetic drugs for Alzheimer’s and Parkinson’s diseases: repurposing insulin, metformin, and thiazolidinediones. Int Rev Neurobiol2020; 155: 37–64.
33.
TangWLiYLiY, et al.A novel player in cognitive decline. Neurosci Biobehav Rev2021; 129: 95–106.
34.
TangWYanCHeS, et al.Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis. Cell Commun Signal2023; 21: 357.
35.
HegdeVVijayanMKumarS, et al.Adenovirus 36 improves glycemic control and markers of Alzheimer’s disease pathogenesis. Biochim Biophys Acta-Mol Basis Dis2019; 1865: 165531.
36.
LuoJNingJChenZ, et al.The role of mitochondrial quality control in cognitive dysfunction in diabetes. Neurochem Res2022; 47: 2158–2172.
37.
SripetchwandeeJChattipakornNChattipakornSC. Links between obesity-induced brain insulin resistance, brain mitochondrial dysfunction, and dementia. Front Endocrinol2018; 9: 496.
38.
RazaHHowarthJACF. Increased oxidative stress and mitochondrial dysfunction in Zucker diabetic rat liver and brain. Cell Physiol Biochem2015; 35: 1241–1251.
39.
SubramaniamSChesseletMF. Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Prog Neurobiol2013; 106: 17–32.
40.
KowluruRAKowluruAMishraM, et al.Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res2015; 48: 40–61.
41.
ChoiJRavipatiANimmagaddaV, et al.Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes. Mitochondrion2014; 18: 41–48.
AnJSuJSunG, et al.Liraglutide alleviates cognitive deficit in db/db mice: involvement in oxidative stress, iron overload, and ferroptosis. Neurochem Res2022; 47: 279–294.
44.
WangZXiaPHuJ, et al.LncRNA MEG3 alleviates diabetic cognitive impairments by reducing mitochondrial-derived apoptosis through promotion of FUNDC1-related mitophagy via Rac1-ROS axis. ACS Chem Neurosci2021; 12: 2280–2307.
45.
LanRWuJWuT, et al.Mitophagy is activated in brain damage induced by cerebral ischemia and reperfusion via the PINK1/Parkin/p62 signalling pathway. Brain Res Bull2018; 142: 63–77.
46.
WangXQiLChengY, et al.PINK1 Overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer’s disease. Acta Pharmacol Sin2022; 43: 1916–1927.
47.
WangXMichaelisEK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci2010; 2: 12.
48.
HuYZhouYYangY, et al.Metformin protects against diabetes-induced cognitive dysfunction by inhibiting mitochondrial fission protein DRP1. Front Pharmacol2022; 13: 832707.
49.
DewanjeeSChakrabortyPBhattacharyaH, et al.Altered glucose metabolism in Alzheimer’s disease: role of mitochondrial dysfunction and oxidative stress. Free Radic Biol Med2022; 193: 134–157.
SuSWuYWangD, et al.Inhibition of excessive autophagy and mitophagy mediates neuroprotective effects of URB597 against chronic cerebral hypoperfusion. Cell Death Dis2018; 9: 733.
52.
ZhangYHeYWuM, et al.Rehmapicroside ameliorates cerebral ischemia-reperfusion injury via attenuating peroxynitrite-mediated mitophagy activation. Free Radic Biol Med2020; 160: 526–539.
53.
Martinez-VicenteM. Neuronal mitophagy in neurodegenerative diseases. Front Mol Neurosci2017; 10: 64.
54.
PaulSSahaDBkB. Mitochondrial dysfunction and mitophagy closely cooperate in neurological deficits associated with Alzheimer’s disease and type 2 diabetes. Mol Neurobiol2021; 58: 3677–3691.
55.
YuHLiuYHeT, et al.Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients. Aging Cell2021; 20: e13469.
56.
HoffmanWHShackaJJAndjelkovicAV. Autophagy in the brains of young patients with poorly controlled T1DM and fatal diabetic ketoacidosis. Exp Mol Pathol2012; 93: 273–280.
57.
NguyenTTTaQTHNguyenTKO, et al.Type 3 diabetes and its role implications in Alzheimer’s disease. IJMS2020; 21: 3165.
58.
FangEFHouYPalikarasK, et al.Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci2019; 22: 401.
59.
CarvalhoCSantosMSOliveiraCR, et al.Alzheimer’s disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers. Biochim Biophys Acta-Mol Basis Dis2015; 1852: 1665–1675.
60.
ManczakMKandimallaRYinX, et al.Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer’s disease. Hum Mol Genet2018; 27: 1332–1342.
61.
ReddyPHYinXManczakM, et al.Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease. Hum Mol Genet2018; 27: 2502–2516.
62.
SuCShenZCuiR, et al.Thioredoxin-interacting protein (TXNIP) regulates Parkin/PINK1-mediated mitophagy in dopaminergic neurons under high-glucose conditions: implications for molecular links between Parkinson’s disease and diabetes. Neurosci Bull2020; 36: 346–358.
63.
WangHFuJXuX, et al.Rapamycin activates mitophagy and alleviates cognitive and synaptic plasticity deficits in a mouse model of Alzheimer’s disease. J Gerontol Ser A-Biol Sci Med Sci2021; 76: 1707–1713.
64.
LouGPalikarasKLautrupS, et al.Mitophagy and neuroprotection. Trends Mol Med2020; 26: 8–20.
65.
BlagovANedosugovaLKirichenkoT, et al.Mitochondrial dysfunction as a factor of energy metabolism disorders in type 2 diabetes mellitus. Front Biosci (Schol Ed)2024; 16: 5.
66.
NguyenTTTaQTHNguyenTTD, et al.Role of insulin resistance in the Alzheimer’s disease progression. Neurochem Res2020; 45: 1481–1491.
67.
CasleyCSCanevariLLandJM, et al.Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem2002; 80: 91–100.
68.
KwonBGamacheTLeeHK, et al.Synergistic effects of β-amyloid and ceramide-induced insulin resistance on mitochondrial metabolism in neuronal cells. Biochim Biophys Acta-Mol Basis Dis2015; 1852: 1810–1823.
69.
ZhaoZYanJHuangL, et al.Phytochemicals targeting Alzheimer’s disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action. Biomed Pharmacother2024; 173: 116373.
70.
PradeepkiranJAHindleAKshirsagarS, et al.Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?Biomed Pharmacother2022; 149: 112918.
71.
ChandrasekaranKChoiJArvasMI, et al.Nicotinamide mononucleotide administration prevents experimental diabetes-induced cognitive impairment and loss of hippocampal neurons. Int J Mol Sci2020; 21: 3756.
72.
SuCShenZCuiR, et al.Thioredoxin-interacting protein (TXNIP) regulates Parkin/PINK1-mediated mitophagy in dopaminergic neurons under high-glucose conditions: implications for molecular links between Parkinson’s disease and diabetes. Neurosci Bull2020; 36: 346–358.
